Manufacturing and Production
Santen launches Ducressa for post-cataract surgery
August 16, 2022 Manufacturing and Production
Treatment involves a combination of levofloxacin and dexamethasone for use after cataract surgery Santen has announced the launch of Ducressa …
The impact of COVID-19 on the fight against AMR
August 16, 2022 Manufacturing and Production
How the responses to the COVID-19 pandemic have affected antibiotic-resistant bacteria Responses to the COVID-19 pandemic may have impacted …
BrainStorm’s ALS-combatting drug finally on its way to the FDA
August 16, 2022 Manufacturing and Production
BrainStorm Cell Therapeutics’ NurOne was rejected by the Food and Drug Association in February 2021 but this year, after consulting …
UK first country to approve bivalent booster which targets both original COVID-19 as well as the Omicron strain
August 16, 2022 Manufacturing and Production
The UK medicines regulator (MHRA) has given the Moderna-made vaccine conditional approval, backed up by the Joint Committee on Vaccination …
US doctor warns of many undiagnosed polio cases
August 9, 2022 Manufacturing and Production
A doctor in New York State has warned that there could be hundreds, or even thousands, of undiagnosed cases of …
FDA approves Myovant Sciences and Pfizer’s treatment for endometriosis pain
August 9, 2022 Manufacturing and Production
The FDA has approved MYFEMBREE as a one-pill, once-a-day therapy for the management of moderate to severe pain associated with …
SMC accepts first licensed treatment for newly diagnosed AL amyloidosis
August 9, 2022 Manufacturing and Production
The SMC has accepted the first licensed treatment for adults with newly diagnosed systemic light chain (AL) amyloidosis. Darzalex® (daratumumab) …
Patients’ cancers should be genetically profiled to improve care, health experts say
August 9, 2022 Manufacturing and Production
A consensus group of leading experts have shared that the NHS should offer all cancer patients genetic profiling of their …
MHRA grant marketing authorisation for sickle cell anaemia treatment
July 26, 2022 Manufacturing and Production
Global Blood Therapeutics (GBT) has announced the MHRA marketing authorisation for Oxbryta® (voxelotor) for the treatment of haemolytic anaemia due …
HealthTrackRx develops monkeypox-specific PCR test with next-day results
July 26, 2022 Manufacturing and Production
HealthTrackRx is now offering a molecular test for detection of the human monkeypox virus. The test was developed by the …
Shift in drinking patterns could lead to 150,000 more cases of disease in England
July 26, 2022 Manufacturing and Production
New modelling research carried out by the Institute of Alcohol Studies (IAS) and Health Lumen, has found that if alcohol …
CHMP issues positive recommendation to first and only biologic for asthma patients
July 26, 2022 Manufacturing and Production
AstraZeneca’s Tezspire (tezepelumab) has been recommended for marketing authorisation in the EU, as an add-on therapy in patients 12 years …
Brain cancer treatment receives Orphan Drug Designation
July 19, 2022 Manufacturing and Production
The FDA has granted an Orphan Drug Designation for DSP-0390, an investigational emopamil-binding protein (EBP) inhibitor for the treatment of …
MIT research demonstrates potential of self-boosting vaccines
July 19, 2022 Manufacturing and Production
In a new study, MIT researchers describe the analysis of a release mechanism from biodegradable core-shell microparticles.Through understanding how and …
New reforms aim for better NHS dental service access
July 19, 2022 Manufacturing and Production
Patients across the country will benefit from improved access to dental care under changes announced by NHS England, the organisation …
Latest content
